{
  "docId": "019dd923-622c-750b-8b9a-40e2965928db",
  "docSlug": "e5bffbaac707",
  "documentTitle": "TransMedics (TMDX)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-10 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 276,
  "pageCount": 342,
  "prevPage": 275,
  "nextPage": 277,
  "slideType": "testimonial",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a Q&A format to highlight a specific expert's negative sentiment toward TransMedics.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-40e2965928db/276",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db#slide-276",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "A surgeon who directs the program expects to terminate their usage in the next 6-12 months: \"Yes, it will go to zero.\"",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-5373-719d-a988-0ce6eec6b02e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.26
      },
      "kind": "paragraph",
      "text": "The surgeon is actively shopping for new, competing devices at a quarter of the cost, such LifePort or XVIVO; and noted that centers which have already made the switch now “don’t use TransMedics ever, very rarely...they use their own pump...Wash U in St. Louis, you should talk to [redacted]...they don’t use TransMedics”; “I’m very interested in their platform.” The surgeon warned that “if I were an investor, I would be very wary of investing in TransMedics...I don’t the field is going to move in their direction....we are going to get other options...there is going to be competition.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f27f7cb-fe30-4120-92c3-b071201f8985",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.48,
        "w": 0.86,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "quote",
      "text": "Shopping for alternatives and TransMedics likely to “go to zero” shortly. A: “As a surgeon, I am still going to use TransMedics now. But I am definitely shopping. I’m shopping for other options.” Q: “And when do you think it’ll impact your use of TransMedics, particularly for liver?” A: “Once we get a pump here at [center redacted] that we like, we’re looking—so, XVIVO, they also have a hypothermic pump like LifePort. They are not FDA-approved in the United States. They are widely used in Europe, so they’ve been incredibly successful in Europe and I’m very interested in their platform because they have excellent outcomes on their pump and they have a back-to-base model, which would allow the transplant center to buy their pump, use their own procurement team, and pump livers at home, and it’s a lot cheaper, like $20,000 versus $80,000. I would like to buy a pump in the next year, either LifePort or XVIVO and have that option for my team so that we don’t have to use TransMedics.” Q: “Once you do that, does your volume of TransMedics go close to zero?” A: “Yes, it will go to zero.” Q: “And do you think this is a realistic possibility in the next 6-12 months?” A: “I think it is. I think the centers that have LifePort, for example, they don’t use TransMedics ever, very rarely. They use their own pump. Or Wash U in St Louis, you should talk to [surgeon name redacted]. They don’t use TransMedics; they use their own pump... if I were an investor, I would be very wary of investing in TransMedics. I don’t think the field is going to move in their direction. I think it’s still going to be judicious utilization of the pump because of the cost associated with the pump, and I think we are going to get other options. There is going to be competition.” – Chief of transplant surgery at a major transplant center; high-volume TransMedics user",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7c4eda8-f14f-4ffe-8597-c51b8e29a7c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Yes, it will go to zero.\" — Chief of transplant surgery at a major transplant center; high-volume TransMedics user",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-5373-719d-a988-1085c822e810",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1eb365b1-ac36-4cd7-9a46-22152a0b04f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.86,
        "x": 0.07,
        "y": 0.19
      },
      "kind": "title",
      "text": "A surgeon who directs the program expects to terminate their usage in the next 6-12 months: “Yes, it will go to zero.”",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c5d9977-c51d-4949-b1c2-9df3577ac63e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "A CA-based transplant center – one of the largest in the country by volume of liver transplants and a heavy OCS user – illustrates the disillusionment with TransMedics rapidly unfolding in the transplant field in recent months.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e17232b2-0b5c-4eda-8320-95a697a49e96",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "7ba82a1c-d789-4e92-9c08-acb9f74f0a31",
      "evidence": "The slide has an action title 'A surgeon who directs the program expects to terminate their usage in the next 6-12 months: “Yes, it will go to zero.”'",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}